SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as investors speculate about a potential buyout amid strong volume, while the community remains divided over management's leadership and the stock's significant undervaluation relative to its revenue. Discussions are heavily focused on the company's long-term potential in rare disease genetic therapies versus its ongoing struggle to break out of a persistent downtrend.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing intense community focus surrounding its upcoming annual shareholder meeting and the strategic expansion of its manufacturing capacity, which many investors view as a critical inflection point for transitioning from R&D to commercial shipments. While the stock has faced downward pressure, bulls remain optimistic that the company's recent paid development agreements with high-power customers and a massive production ramp-up target provide a strong foundation for future revenue growth, especially as investors closely monitor developments regarding the company's U.S. redomiciliation.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is experiencing significant volatility and social media attention following the announcement of a new distribution deal with NBCUniversal and the start of the FIFA World Cup, both viewed by the community as key catalysts for growth. Investors are actively debating the stock's potential for a short squeeze due to high short interest and limited float, while many remain focused on whether these developments can restore long-term value against a backdrop of past management challenges and subscriber churn concerns.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is trending as investors aggressively rotate capital into memory and storage leaders, driven by sticky demand in AI data centers and ongoing supply-side constraints. The community remains heavily focused on potential supply chain bottlenecks and the cyclical versus structural nature of the current memory rally, leading to high-volume price swings and intense debate over the sustainability of recent gains.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending as retail investors speculate on potential inclusion in the Russell 1000 index, fueling intense debate regarding the stock's future liquidity and its ongoing battle between bullish long-term sentiment and heavy short interest. While the community remains divided over the outcome of index rebalancing, investors are primarily focused on upcoming regulatory milestones and the long-term commercialization potential of the company's immunotherapy platform.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors react to management’s renewed focus on a potential eBay acquisition and the CEO’s decision to waive his performance pay package. The community remains deeply divided, with bulls pointing to improved EBITDA guidance as evidence of a structural turnaround, while skeptics express frustration over years of sideways price action and ongoing debates regarding dilution and short interest.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is facing significant downward pressure following the announcement of an all-stock acquisition of Synaptics, which has triggered immediate market concern regarding dilution and the strategic focus of the deal. While some community members view the dip as an oversold opportunity driven by structural optics rather than a fundamental collapse, others are actively debating the timing and valuation, leading to high-volume volatility as arbitrage traders position themselves.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending as investors react to a positive FDA assessment of its mRNA-1010 flu vaccine ahead of a pivotal advisory committee vote. The community is actively debating the company's long-term potential in the oncology and rare disease markets, while closely monitoring organizational shifts and potential policy changes regarding vaccine funding.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

Atai is currently navigating market volatility following its recent Russell index inclusion and the sector-wide optimism surrounding regulatory fast-tracking for psychedelic therapies. While the community remains focused on the potential for a major partnership or acquisition deal, some investors are expressing frustration over the stock's inability to hold gains after price spikes.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is currently trending as investors focus on its commercial execution, consistent revenue growth, and the anticipation of key legislative and legal catalysts impacting the nephrology sector. The community is actively debating the company's valuation relative to its pipeline potential and the long-term impact of its ongoing reimbursement challenges.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Boston Private is a premier Wealth Management and Private Banking organization that owns affiliates in New England, New York, Los Angeles and the San Francisco Bay Area.  The Company positions its affiliates to serve the high net worth marketplace with high quality products and services of unique appeal to private clients.

Boston Private Financial Holdings Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

BPFHBoston Private Financial Holdings Inc.

Latest BPFH News